Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05203198 · ClinicalTrials.gov registry record · NA
The PATHway Study: Primary Care Based Depression Prevention in Adolescents
A NA study of Depression and Mental Disorder in Adolescence, sponsored by University of Illinois at Chicago.
- Active
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 6
- Study locations
NCT05203198 is a NA study of Depression and Mental Disorder in Adolescence that is active but no longer recruiting, run by University of Illinois at Chicago. The registered enrollment target is 400 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (49% lower). The trial reports 6 study locations across 2 states.
The verdict
NCT05203198, a NA study of Depression and Mental Disorder in Adolescence, is active but no longer recruiting, sponsored by University of Illinois at Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 6
- Study locations
Study Summary
Prevention of depressive disorders has become a key priority for the NIMH, but the investigators have no widely available public health strategy to reduce morbidity and mortality. To address this need, the investigators developed and evaluated the primary care based-technology "behavioral vaccine," Competent Adulthood Transition with Cognitive-Behavioral Humanistic and Interpersonal Therapy (CATCH-IT). The investigators will engage N=4 health systems representative of the United States health care system, and conduct a factorial design study to optimize the intervention in preparation for an implementation study and eventual dissemination.
Conditions Studied
Interventions
- BEHAVIORAL Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training
Study Locations (6)
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
- UI Health - Chicago
- University of Chicago Comer Children's Hospital - Chicago
- Northshore University HealthSystem - Glenview
- Advocate Aurora Health - Park Ridge
Texas
- UT Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2026-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05203198
The ClinicalTrials.gov registry entry for NCT05203198 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (49% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training is the first listed.
NCT05203198 reports 6 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Texas.
Frequently Asked Questions
What is clinical trial NCT05203198 about?
NCT05203198 is a clinical study titled "The PATHway Study: Primary Care Based Depression Prevention in Adolescents". Prevention of depressive disorders has become a key priority for the NIMH, but the investigators have no widely available public health strategy to reduce morbidity and mortality. To address this need, the investigators developed and evaluated the primary care based-technology "behavioral vaccine," ...
What is the current status of trial NCT05203198?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2022-02-01. Estimated completion is 2026-10-31.
What conditions does trial NCT05203198 study?
This clinical trial studies the following conditions: Depression, Mental Disorder in Adolescence.
What interventions are being tested in trial NCT05203198?
The interventions under investigation include: Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05203198?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05203198 being conducted?
This trial has 6 study locations across Illinois, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.